Jazz Pharmaceuticals PLC (JAZZ) — Working Capital to Net Assets Ratio
Jazz Pharmaceuticals PLC (JAZZ) has a Working Capital to Net Assets ratio of 51.6% as of March 2026. Working capital of $2.34 Billion (current assets of $4.58 Billion minus current liabilities of $2.25 Billion) is measured against net assets of $4.53 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jazz Pharmaceuticals PLC liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jazz Pharmaceuticals PLC Working Capital to Net Assets (2005–2025)
This chart shows how Jazz Pharmaceuticals PLC's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 51.6%, reflecting working capital of $2.34 Billion against net assets of $4.53 Billion USD. For the complete balance sheet picture, see Jazz Pharmaceuticals PLC assets under control.
Annual Working Capital to Net Assets for Jazz Pharmaceuticals PLC (2005–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jazz Pharmaceuticals PLC from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check JAZZ asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 44.5% | $1.92 Billion | $4.32 Billion | $4.17 Billion | $2.24 Billion | ▼ -43.2 pp |
| 2024 | 87.7% | $3.59 Billion | $4.09 Billion | $4.63 Billion | $1.04 Billion | ▲ +36.9 pp |
| 2023 | 50.8% | $1.90 Billion | $3.74 Billion | $3.44 Billion | $1.54 Billion | ▼ -3.4 pp |
| 2022 | 54.2% | $1.67 Billion | $3.09 Billion | $2.61 Billion | $933.19 Million | ▲ +8.8 pp |
| 2021 | 45.4% | $1.80 Billion | $3.97 Billion | $2.61 Billion | $809.30 Million | ▼ -14.3 pp |
| 2020 | 59.7% | $2.19 Billion | $3.66 Billion | $2.84 Billion | $653.75 Million | ▲ +19.0 pp |
| 2019 | 40.7% | $1.27 Billion | $3.11 Billion | $1.63 Billion | $364.49 Million | ▲ +8.5 pp |
| 2018 | 32.2% | $888.52 Million | $2.76 Billion | $1.23 Billion | $345.49 Million | ▲ +7.4 pp |
| 2017 | 24.9% | $674.33 Million | $2.71 Billion | $968.28 Million | $293.95 Million | ▼ -1.3 pp |
| 2016 | 26.1% | $490.66 Million | $1.88 Billion | $748.07 Million | $257.41 Million | ▼ -38.4 pp |
| 2015 | 64.5% | $1.03 Billion | $1.60 Billion | $1.26 Billion | $226.64 Million | ▲ +6.2 pp |
| 2014 | 58.3% | $799.04 Million | $1.37 Billion | $1.02 Billion | $216.80 Million | ▲ +7.3 pp |
| 2013 | 51.0% | $660.59 Million | $1.30 Billion | $864.62 Million | $204.03 Million | ▲ +18.9 pp |
| 2012 | 32.1% | $360.03 Million | $1.12 Billion | $551.57 Million | $191.54 Million | ▼ -43.8 pp |
| 2011 | 75.9% | $146.26 Million | $192.79 Million | $199.13 Million | $52.87 Million | ▲ +28.3 pp |
| 2010 | 47.5% | $14.52 Million | $30.55 Million | $74.46 Million | $59.94 Million | ▲ +16.9 pp |
| 2009 | 30.6% | $-22.29 Million | $-72.83 Million | $36.95 Million | $59.24 Million | ▼ -108.8 pp |
| 2008 | 139.4% | $-129.49 Million | $-92.88 Million | $44.00 Million | $173.49 Million | ▼ -4.7 pp |
| 2007 | 144.1% | $79.23 Million | $54.99 Million | $116.09 Million | $36.86 Million | ▲ +178.7 pp |
| 2006 | -34.6% | $61.04 Million | $-176.30 Million | $91.56 Million | $30.52 Million | ▼ -27.8 pp |
| 2005 | -6.8% | $8.05 Million | $-118.25 Million | $31.38 Million | $23.34 Million | — |